- Home
- VMAR vs OGEN Comparison
VMAR vs OGEN Comparison
Compare VMAR & OGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- OGEN
- Stock Information
- Founded
- VMAR 1995
- OGEN 1996
- Country
- VMAR Canada
- OGEN United States
- Employees
- VMAR N/A
- OGEN N/A
- Industry
- VMAR Marine Transportation
- OGEN Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- OGEN Health Care
- Exchange
- VMAR Nasdaq
- OGEN Nasdaq
- Market Cap
- VMAR 5.1M
- OGEN 4.6M
- IPO Year
- VMAR 2020
- OGEN N/A
- Fundamental
- Price
- VMAR $6.62
- OGEN $0.20
- Analyst Decision
- VMAR Strong Buy
- OGEN
- Analyst Count
- VMAR 1
- OGEN 0
- Target Price
- VMAR $2,700.00
- OGEN N/A
- AVG Volume (30 Days)
- VMAR 35.6K
- OGEN 351.6K
- Earning Date
- VMAR 07-14-2025
- OGEN 05-09-2025
- Dividend Yield
- VMAR N/A
- OGEN N/A
- EPS Growth
- VMAR N/A
- OGEN N/A
- EPS
- VMAR N/A
- OGEN N/A
- Revenue
- VMAR $1,612,492.00
- OGEN N/A
- Revenue This Year
- VMAR $120.43
- OGEN N/A
- Revenue Next Year
- VMAR N/A
- OGEN N/A
- P/E Ratio
- VMAR N/A
- OGEN N/A
- Revenue Growth
- VMAR N/A
- OGEN N/A
- 52 Week Low
- VMAR $4.04
- OGEN $0.16
- 52 Week High
- VMAR $1,039.50
- OGEN $3.43
- Technical
- Relative Strength Index (RSI)
- VMAR 52.65
- OGEN 52.52
- Support Level
- VMAR $6.28
- OGEN $0.18
- Resistance Level
- VMAR $7.40
- OGEN $0.22
- Average True Range (ATR)
- VMAR 0.64
- OGEN 0.02
- MACD
- VMAR 0.05
- OGEN 0.00
- Stochastic Oscillator
- VMAR 61.05
- OGEN 66.67
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company include Bruce 22, Fantail 217, Volt 180, and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from the Sale of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.